India’s Manipal Education & Medical Group (MEMG) is actively working with a consortium of international lenders to raise approximately ₹40 billion (US$466 million), aimed at funding its acquisition of Sahyadri Hospitals — a key regional healthcare provider.
The financing discussions, according to industry sources, include major global institutions such as DBS Group, Deutsche Bank, JPMorgan Chase, and Standard Chartered. The capital raise may be structured via Indian rupee-denominated bonds or medium-term loans spanning three to five years. While the deal is still in negotiation stages, it marks one of the largest acquisition-linked raises in India’s private healthcare sector this year.
Strategic Backing from Temasek and Global Pension Capital
Manipal’s aggressive expansion push is backed by Singapore’s sovereign investor Temasek Holdings, reaffirming the group’s long-term commitment to scaling healthcare delivery across urban and Tier-II cities in India. The deal follows Ontario Teachers’ Pension Plan Board divesting its controlling interest in Sahyadri to Manipal earlier this month — a sign of realignment among global institutional investors in Indian healthcare assets.
Sahyadri operates a notable network of hospitals across Maharashtra, and its integration into the Manipal portfolio is expected to significantly enhance clinical capacity, regional footprint, and synergies in specialist care delivery.
A Broader Signal: Private Credit Rising in Indian M&A
This move is emblematic of a larger trend: international lenders and private credit funds are becoming increasingly active in India’s acquisition financing landscape. As highlighted by EY in recent consulting analysis, the country’s underpenetrated yet high-growth healthcare sector is emerging as a preferred domain for foreign capital deployment, especially in the form of bespoke, deal-specific structured credit.
The Manipal–Sahyadri deal not only underscores the growing appetite for hospital consolidation but also reflects confidence in India’s health infrastructure reforms and rising consumer spend on premium care.
What This Means for the Market
From a strategic perspective, this acquisition raises several flags of opportunity and caution:
- Healthcare Consolidation is Accelerating: Mid-sized regional hospital chains are becoming attractive acquisition targets for national groups seeking scale and operational leverage.
- Private Credit is the New Growth Engine: As traditional lending tightens, global private credit and structured lending vehicles are stepping in to finance growth-stage M&A in India.
- Global Funds are Shifting Gears: With pension funds and sovereign players like Temasek and OTPP reshuffling assets, there’s a renewed focus on active value creation in Indian healthcare — not just passive investing.
